nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

12.03.2018 | Letter to the Editor

Is it time to change our vision of tumor metabolism prior to immunotherapy?

verfasst von: Fabio Grizzi, Angelo Castello, Egesta Lopci

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Takada K, Toyokawa G, Okamoto T, et al. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on 18 F-fluorodeoxyglucose positron emission tomography/computed tomography. Cancer Med. 2017;6(11):2552–61.CrossRefPubMedPubMedCentral

Liu J, Dong M, Sun X, et al. Prognostic value of 18F-FDG PET7CT in surgical non-small cell lung cancer: a meta-analysis. PLoS One. 11(1):e0146195.

Toyokawa G, Takada K, Okamoto T, et al. Elevated metabolic activity on 18F-FDG PET/CT is associated with the expression of EZH2 in non-small cell lung cancer. Anticancer Res. 2017;37:1393–402.CrossRefPubMed

Lopci E, Rossi S. Tumor metabolism and prognostic role of EZH2 in non-small cell lung cancer. Transl Cancer Res. 2017;6:S982–8.CrossRef

Palsson-McDermott EM, O’Neill LAJ. The Warburg effect then and now: from cancer to inflammatory diseases. BioEssays. 2013;35:965–73.CrossRefPubMed

Lopci E, Toschi L, Grizzi F, et al. Correlation of metabolic information on FD-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery. Eur J Nucl Med Mol Imaging. 2016;43:1954–61.CrossRefPubMed

Horne ZD, Jack R, Gray ZT, et al. Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer. J Surg Res. 2011;171:1–5.CrossRefPubMed

Tumeh PC, Harview CL, Yearley JH, et al. PD-1 blockade induces responses to inhibiting adaptive immune resistence. Nature. 2014;515:568–71.CrossRefPubMedPubMedCentral

Lopci E, Grizzi F, Russo C, et al. Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis. Nucl Med Commun. 2017;38:340–6.CrossRefPubMed

10.

Rashidian M, Ingram JR, Dougan M, et al. Predicting the response to CTLA-4 blocjage by longitudinal noninvasive monitoring of CD8 T cells. J Exp Med. 2017;214:2243.CrossRefPubMedPubMedCentral

Titel: Is it time to change our vision of tumor metabolism prior to immunotherapy?
verfasst von: Fabio Grizzi
Angelo Castello
Egesta Lopci
Publikationsdatum: 12.03.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2018
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-018-3988-1

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images

Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis

Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment

Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment

Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent